Blinking eye-on-a-chip
Researchers from the University of Pennsylvania have created an eye-on-a-chip with a mechanical eyelid simulating blinking to test experimental drugs for dry eye disease (DED).The research, published
Staff reporters2 min read
Dry Eye
OSL: Comparing symptom questionnaires
Validated questionnaires are routinely used to screen for symptoms of dry eye disease prior to the clinical evaluation of ocular surface and tear film parameters. The recent TFOS DEWS II Diagnostic
Dr Michael Wang, Dr Ally Xue and A/Prof Jennifer Craig2 min read
OSL: Studying DED epidemiology
The Ocular Surface Laboratory (OSL) is continuing its endeavours into shedding light on the natural history of dry eye disease (DED) development. Recent studies have explored risk factors for dry eye
Dr Alex Muntz2 min read
DNase for severe dry eye?
Researchers at the University of Illinois at Chicago have released promising results from a phase I/II clinical trial for a new enzyme-based treatment for severe dry eye.The trial compared eye drops
Staff reporters2 min read
rhNGF for dry eye?
A phase I clinical trial in Italy has shown recombinant human nerve growth factor (rhNGF) to be a potential treatment for dry eye disease (DED).A total of 40 patients with moderate to severe,
Staff reporters1 min read
Botox for dry eye?
Dry eye symptoms and photophobia improved in patients suffering chronic migraine when treated with botulinum toxin A (BoNT-A) injections.The study of 76 patients at Miami Veterans Affairs Medical
Staff reporters1 min read
Dry eye research review
This is a randomised, prospective intervention study that evaluated the effectiveness of platelet-rich plasma (PRP) injections in the treatment of severe, aqueous-deficient dry eye. PRP is a blood derivative that has previously been successfully used to treat ocular surface disorders such as persist
Ryan Mahmoud5 min read
Manuka honey cream for blepharitis
Blepharitis is an epidemic – defined as inflammation affecting the eyelashes, eyelids and the ocular surface, it is widely recognised as one of the most common ocular conditions.
Associate Professor Jennifer Craig and Dr Andrea Cruzat9 min read
New co-management conference
Re:Vision’s new Co-Management Conference on Sunday 11 August to be held at its surgery in Mt Wellington, Auckland, promises to be the first of its kind in New Zealand, said organisers.
Staff reporters1 min read
NGF for DED?
A trial using recombinant human nerve growth factor (rhNGF) eye drops to treat dry eye disease has had promising results.
Staff reporters1 min read
Shrew clue for dry eye?
Breakthroughs in healthcare can come from unusual places, said Assistant Professor Jianzhong Chen, and he and his colleagues may have discovered a new one for dry eye.
Staff reporters1 min read